Formulators Push for Documented Compositional Consistency Standards
Aromatherapy and pharmaceutical formulators replacing synthetic flavor programs under mounting purity verification pressure are increasingly specifying extractors with documented compositional-consistency certification standing over bulk-commodity equivalents in vendor selection decisions across most major premium-focused programs. Synthite and Kancor have both expanded certified distillation-testing capacity over the past two years to serve this growing procurement demand. At least a dozen major formulators have qualified new certified compositional-consistency partnerships since 2023, and extractors report this shift is meaningfully expanding addressable procurement demand across multiple program categories, with several additional formulators evaluating comparable programs soon across additional premium markets internationally.
Market Impact: Sustains 5%+ deployment-linked growth yearly








